Cargando…
S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428346/ http://dx.doi.org/10.1097/01.HS9.0000967636.72750.f1 |
| _version_ | 1785090446596243456 |
|---|---|
| author | Röth, Alexander He, Guangsheng Brodsky, Andres Chai-Adisaksopha, Chatree Chatree Dumagay, Teresita Demichelis, Roberta Höglund, Martin Kelly, Richard Lee, Je-Hwan Nishimura, Jun-Ichi Obara, Naoshi Risitano, Antonio Maria Gaya, Anna Appius, Anita Gentile, Brittany Negricea, Raluca Zhang, Zilu Buatois, Simon Han, Bing |
| author_facet | Röth, Alexander He, Guangsheng Brodsky, Andres Chai-Adisaksopha, Chatree Chatree Dumagay, Teresita Demichelis, Roberta Höglund, Martin Kelly, Richard Lee, Je-Hwan Nishimura, Jun-Ichi Obara, Naoshi Risitano, Antonio Maria Gaya, Anna Appius, Anita Gentile, Brittany Negricea, Raluca Zhang, Zilu Buatois, Simon Han, Bing |
| author_sort | Röth, Alexander |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428346 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283462023-08-17 S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS Röth, Alexander He, Guangsheng Brodsky, Andres Chai-Adisaksopha, Chatree Chatree Dumagay, Teresita Demichelis, Roberta Höglund, Martin Kelly, Richard Lee, Je-Hwan Nishimura, Jun-Ichi Obara, Naoshi Risitano, Antonio Maria Gaya, Anna Appius, Anita Gentile, Brittany Negricea, Raluca Zhang, Zilu Buatois, Simon Han, Bing Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428346/ http://dx.doi.org/10.1097/01.HS9.0000967636.72750.f1 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Röth, Alexander He, Guangsheng Brodsky, Andres Chai-Adisaksopha, Chatree Chatree Dumagay, Teresita Demichelis, Roberta Höglund, Martin Kelly, Richard Lee, Je-Hwan Nishimura, Jun-Ichi Obara, Naoshi Risitano, Antonio Maria Gaya, Anna Appius, Anita Gentile, Brittany Negricea, Raluca Zhang, Zilu Buatois, Simon Han, Bing S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title | S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title_full | S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title_fullStr | S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title_full_unstemmed | S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title_short | S181: THE PHASE III, RANDOMIZED COMMODORE 2 TRIAL: RESULTS FROM A MULTICENTER STUDY OF CROVALIMAB VS ECULIZUMAB IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) PATIENTS NAIVE TO COMPLEMENT INHIBITORS |
| title_sort | s181: the phase iii, randomized commodore 2 trial: results from a multicenter study of crovalimab vs eculizumab in paroxysmal nocturnal hemoglobinuria (pnh) patients naive to complement inhibitors |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428346/ http://dx.doi.org/10.1097/01.HS9.0000967636.72750.f1 |
| work_keys_str_mv | AT rothalexander s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT heguangsheng s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT brodskyandres s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT chaiadisaksophachatreechatree s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT dumagayteresita s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT demichelisroberta s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT hoglundmartin s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT kellyrichard s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT leejehwan s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT nishimurajunichi s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT obaranaoshi s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT risitanoantoniomaria s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT gayaanna s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT appiusanita s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT gentilebrittany s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT negricearaluca s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT zhangzilu s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT buatoissimon s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors AT hanbing s181thephaseiiirandomizedcommodore2trialresultsfromamulticenterstudyofcrovalimabvseculizumabinparoxysmalnocturnalhemoglobinuriapnhpatientsnaivetocomplementinhibitors |